COMMUNIQUÉS West-GlobeNewswire

Nyxoah’s Genio® Wins Prix Galien UK 2026 Award for Best Medical Technology
15/06/2026
Nyxoah’s Genio® Wins Prix Galien UK 2026 Award for Best Medical Technology Mont-Saint-Guibert, Belgium – June 15, 2026, 10:05 pm CET / 04:05 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company [...]
Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares
15/06/2026
REYKJAVIK, ICELAND (June 15, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients [...]
Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering
15/06/2026
Proceeds expected to be deployed to repay the OrbiMed Purchase Agreement to enhance financial flexibility Additional proceeds used to pay for the capped call with a premium of at least 75% and to repurchase up to $25 [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
15/06/2026
ZUG, Switzerland, June 15, 2026 (GLOBE NEWSWIRE) -- The attached notification relates to the purchase of ordinary shares by a member of the Company’s Executive Committee. Attachment notification-of-managers-transaction- [...]
Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares
15/06/2026
REYKJAVIK, Iceland, June 15, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar [...]
Sanofi: Information concerning the total number of voting rights and shares – May 2026
15/06/2026
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Ethyreal Bio Presents First Preclinical Data on ETHY-001 at ENDO 2026, Demonstrating Complete Blockade of Autoantibody Activation of TSHR and Differentiated Activity in TED
15/06/2026
– ETHY-001 produced complete blockade of autoantibody-mediated TSHR activation across all patient serum samples tested, demonstrating breadth and consistency of effect – – In TED patient-derived orbital fibroblasts, [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions – Mai 2026
15/06/2026
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Confo Therapeutics Announces Encouraging Preclinical Data for Post-bariatric Hypoglycemia Candidate CFTX-2034 at ENDO 2026
15/06/2026
Data support the potential of CFTX-2034 as a first-in-class treatment for PBH and advancement toward Phase 1 clinical development Ghent, Belgium – June 15, 2026 – Confo Therapeutics , a clinical-stage biotechnology [...]
GENFIT : Résultats de l’Assemblée Générale Mixte du 15 juin 2026
15/06/2026
L’ensemble des projets de résolutions recommandés par le Conseil d’Administration a été approuvé (quorum : 32,13 %) Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 15 juin 2026 – GENFIT ( [...]
Boston Business Journal names Interra Health to 2026 Best Places to Work List
15/06/2026
BOSTON, June 15, 2026 (GLOBE NEWSWIRE) -- The Boston Business Journal has named Interra Health to its 2026 Best Places to Work — the BBJ’s exclusive ranking of the Massachusetts companies that have built outstanding [...]
GENFIT: June 15, 2026 Combined Shareholders Meeting Results
15/06/2026
All resolutions recommended by the Board of Directors approved (quorum: 32.13 %) Lille (France); Cambridge, ( Massachusetts, United States); Zurich (Switzerland); June 15, 2026 - GENFIT (Euronext: GNFT) , , a [...]
Major Shareholder Announcement
15/06/2026
Company Announcement Major shareholder announcement for Genmab A/S COPENHAGEN, Denmark; June 15, 2026 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Orbis [...]
Curaechoice Partners with Capitol Imaging Services to Deliver Greater Access to No-Cost Diagnostic Imaging for Program Members
15/06/2026
Partnership Enhances Members’ Access to Comprehensive Imaging Services including MRI, CT, PET/CT, and Women's Health Imaging Across Six Southern States Birmingham, ALABAMA, June 15, 2026 (GLOBE NEWSWIRE) -- Curaechoice [...]
Cardiawave Announces First Routine Treatments Performed with Valvosoft® Following CE Mark Approval and Accelerates Its Deployment
15/06/2026
Cardiawave Announces First Routine Treatments Performed with Valvosoft® Following CE Mark Approval and Accelerates Its Deployment After demonstrating its safety and performance in more than 100 patients during clinical [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 24 - 2026
15/06/2026
Aggregated presentation by day and by market Purchases of own shares from June 8th to June 12th 2026 Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total [...]
Le KFSH montre comment les hôpitaux spécialisés peuvent stimuler l’innovation au sein des systèmes de santé lors du congrès HLTH Europe 2026
15/06/2026
AMSTERDAM, 15 juin 2026 (GLOBE NEWSWIRE) -- À l’occasion de son parrainage et de sa participation au congrès HLTH Europe 2026, qui se tiendra du 15 au 18 juin à Amsterdam, le King Faisal Specialist Hospital & [...]
Wildfire Smoke Reaches Record Levels as Americans Struggle to Breathe
15/06/2026
Betterbrand's BetterLungs supplement supports respiratory health naturally as wildfire season intensifies across the U.S. SAN ANTONIO, TX, June 15, 2026 (GLOBE NEWSWIRE) -- Wildfire Smoke Reaches Record Levels as [...]
Zealand Pharma - Transactions related to share buy-back program (week 24, 2026)
15/06/2026
Company announcement No. 25 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 24, 2026) Copenhagen, Denmark, June 15, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: [...]

Pages